Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse

Gioacchino Calapai, Francesco Corica, Alessandro Allegra, Andrea Corsonello, Lidia Sautebin, Tiziana De Gregorio, Massimo Di Rosa, Giuseppina Costantino, Michele Buemi, Achille P. Caputi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

1. Intracranial administration of leptin reduces both food intake and body weight gain in the mouse. Inhibitors of nitric oxide (NO) synthase produce similar effects. 2. To investigate the role of the brain L-arginine/NO pathway in mediating this effect of leptin, we have evaluated food intake and body weight gain after daily (5 days) intracerebroventricular (i.c.v.) administration of leptin (0.5-2 μg) alone or in association with L-arginine (10 μg). Moreover, we measured diencephalic nitric oxide synthase (NOS) activity after a single i.c.v. leptin (0.25-2 μg) injection and after consecutive doses of leptin (0.25-2 μg over 5 days. The time course of the effect of leptin on NOS activity was also evaluated. 3. I.c.v. injected leptin (1 and 2 μg) significantly and dose-dependently reduced food intake and body weight gain with respect to vehicle (food intake: 5.97 ± 0.16 g 24 h-1 and 4.27 ± 0.18 g 24 h-1, respectively, vs 8.05 ± 0.34 g 24 h-1, P <0.001, n = 6 for each group; body weight gain: -10.7 ± 0.46% and -15.2 ± 0.65%, respectively, vs 5.14 ± 0.38%, P <0.001, n = 6 for each group). This effect was antagonized by L-arginine (food intake: 7.90 ± 0.37 g 24 h; body weight gain: 5.11 ± 0.31%, n = 6). Diencephalic NOS activity was significantly reduced by the highest doses of leptin with respect to vehicle (vehicle: 0.90 ± 0.04 nmol citrulline min-1 g-1 tissue; leptin 1 μg: 0.62 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001; leptin 2 μg: 0.44 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001, n = 6 for each group). Similar results were obtained in animals treated with daily consecutive doses of leptin. The inhibitory effect appeared rapidly (within 30 min) and was long lasting (up to 12 h). 4. Our results suggest that the brain L-arginine/NO pathway may be involved in the central effect of leptin on feeding behaviour and body weight gain in mice.

Original languageEnglish
Pages (from-to)798-802
Number of pages5
JournalBritish Journal of Pharmacology
Volume125
Issue number4
DOIs
Publication statusPublished - 1998

Fingerprint

Leptin
Nitric Oxide Synthase
Weight Gain
Eating
Body Weight
Citrulline
Arginine
Nitric Oxide
Brain
Feeding Behavior

Keywords

  • Body weight gain
  • Brain
  • Food intake
  • L-arginine
  • Leptin
  • Nitric oxide
  • Obesity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. / Calapai, Gioacchino; Corica, Francesco; Allegra, Alessandro; Corsonello, Andrea; Sautebin, Lidia; De Gregorio, Tiziana; Di Rosa, Massimo; Costantino, Giuseppina; Buemi, Michele; Caputi, Achille P.

In: British Journal of Pharmacology, Vol. 125, No. 4, 1998, p. 798-802.

Research output: Contribution to journalArticle

Calapai, Gioacchino ; Corica, Francesco ; Allegra, Alessandro ; Corsonello, Andrea ; Sautebin, Lidia ; De Gregorio, Tiziana ; Di Rosa, Massimo ; Costantino, Giuseppina ; Buemi, Michele ; Caputi, Achille P. / Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. In: British Journal of Pharmacology. 1998 ; Vol. 125, No. 4. pp. 798-802.
@article{2853a28566a3447ba2288fce671e03da,
title = "Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse",
abstract = "1. Intracranial administration of leptin reduces both food intake and body weight gain in the mouse. Inhibitors of nitric oxide (NO) synthase produce similar effects. 2. To investigate the role of the brain L-arginine/NO pathway in mediating this effect of leptin, we have evaluated food intake and body weight gain after daily (5 days) intracerebroventricular (i.c.v.) administration of leptin (0.5-2 μg) alone or in association with L-arginine (10 μg). Moreover, we measured diencephalic nitric oxide synthase (NOS) activity after a single i.c.v. leptin (0.25-2 μg) injection and after consecutive doses of leptin (0.25-2 μg over 5 days. The time course of the effect of leptin on NOS activity was also evaluated. 3. I.c.v. injected leptin (1 and 2 μg) significantly and dose-dependently reduced food intake and body weight gain with respect to vehicle (food intake: 5.97 ± 0.16 g 24 h-1 and 4.27 ± 0.18 g 24 h-1, respectively, vs 8.05 ± 0.34 g 24 h-1, P <0.001, n = 6 for each group; body weight gain: -10.7 ± 0.46{\%} and -15.2 ± 0.65{\%}, respectively, vs 5.14 ± 0.38{\%}, P <0.001, n = 6 for each group). This effect was antagonized by L-arginine (food intake: 7.90 ± 0.37 g 24 h; body weight gain: 5.11 ± 0.31{\%}, n = 6). Diencephalic NOS activity was significantly reduced by the highest doses of leptin with respect to vehicle (vehicle: 0.90 ± 0.04 nmol citrulline min-1 g-1 tissue; leptin 1 μg: 0.62 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001; leptin 2 μg: 0.44 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001, n = 6 for each group). Similar results were obtained in animals treated with daily consecutive doses of leptin. The inhibitory effect appeared rapidly (within 30 min) and was long lasting (up to 12 h). 4. Our results suggest that the brain L-arginine/NO pathway may be involved in the central effect of leptin on feeding behaviour and body weight gain in mice.",
keywords = "Body weight gain, Brain, Food intake, L-arginine, Leptin, Nitric oxide, Obesity",
author = "Gioacchino Calapai and Francesco Corica and Alessandro Allegra and Andrea Corsonello and Lidia Sautebin and {De Gregorio}, Tiziana and {Di Rosa}, Massimo and Giuseppina Costantino and Michele Buemi and Caputi, {Achille P.}",
year = "1998",
doi = "10.1038/sj.bjp.0702121",
language = "English",
volume = "125",
pages = "798--802",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse

AU - Calapai, Gioacchino

AU - Corica, Francesco

AU - Allegra, Alessandro

AU - Corsonello, Andrea

AU - Sautebin, Lidia

AU - De Gregorio, Tiziana

AU - Di Rosa, Massimo

AU - Costantino, Giuseppina

AU - Buemi, Michele

AU - Caputi, Achille P.

PY - 1998

Y1 - 1998

N2 - 1. Intracranial administration of leptin reduces both food intake and body weight gain in the mouse. Inhibitors of nitric oxide (NO) synthase produce similar effects. 2. To investigate the role of the brain L-arginine/NO pathway in mediating this effect of leptin, we have evaluated food intake and body weight gain after daily (5 days) intracerebroventricular (i.c.v.) administration of leptin (0.5-2 μg) alone or in association with L-arginine (10 μg). Moreover, we measured diencephalic nitric oxide synthase (NOS) activity after a single i.c.v. leptin (0.25-2 μg) injection and after consecutive doses of leptin (0.25-2 μg over 5 days. The time course of the effect of leptin on NOS activity was also evaluated. 3. I.c.v. injected leptin (1 and 2 μg) significantly and dose-dependently reduced food intake and body weight gain with respect to vehicle (food intake: 5.97 ± 0.16 g 24 h-1 and 4.27 ± 0.18 g 24 h-1, respectively, vs 8.05 ± 0.34 g 24 h-1, P <0.001, n = 6 for each group; body weight gain: -10.7 ± 0.46% and -15.2 ± 0.65%, respectively, vs 5.14 ± 0.38%, P <0.001, n = 6 for each group). This effect was antagonized by L-arginine (food intake: 7.90 ± 0.37 g 24 h; body weight gain: 5.11 ± 0.31%, n = 6). Diencephalic NOS activity was significantly reduced by the highest doses of leptin with respect to vehicle (vehicle: 0.90 ± 0.04 nmol citrulline min-1 g-1 tissue; leptin 1 μg: 0.62 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001; leptin 2 μg: 0.44 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001, n = 6 for each group). Similar results were obtained in animals treated with daily consecutive doses of leptin. The inhibitory effect appeared rapidly (within 30 min) and was long lasting (up to 12 h). 4. Our results suggest that the brain L-arginine/NO pathway may be involved in the central effect of leptin on feeding behaviour and body weight gain in mice.

AB - 1. Intracranial administration of leptin reduces both food intake and body weight gain in the mouse. Inhibitors of nitric oxide (NO) synthase produce similar effects. 2. To investigate the role of the brain L-arginine/NO pathway in mediating this effect of leptin, we have evaluated food intake and body weight gain after daily (5 days) intracerebroventricular (i.c.v.) administration of leptin (0.5-2 μg) alone or in association with L-arginine (10 μg). Moreover, we measured diencephalic nitric oxide synthase (NOS) activity after a single i.c.v. leptin (0.25-2 μg) injection and after consecutive doses of leptin (0.25-2 μg over 5 days. The time course of the effect of leptin on NOS activity was also evaluated. 3. I.c.v. injected leptin (1 and 2 μg) significantly and dose-dependently reduced food intake and body weight gain with respect to vehicle (food intake: 5.97 ± 0.16 g 24 h-1 and 4.27 ± 0.18 g 24 h-1, respectively, vs 8.05 ± 0.34 g 24 h-1, P <0.001, n = 6 for each group; body weight gain: -10.7 ± 0.46% and -15.2 ± 0.65%, respectively, vs 5.14 ± 0.38%, P <0.001, n = 6 for each group). This effect was antagonized by L-arginine (food intake: 7.90 ± 0.37 g 24 h; body weight gain: 5.11 ± 0.31%, n = 6). Diencephalic NOS activity was significantly reduced by the highest doses of leptin with respect to vehicle (vehicle: 0.90 ± 0.04 nmol citrulline min-1 g-1 tissue; leptin 1 μg: 0.62 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001; leptin 2 μg: 0.44 ± 0.03 nmol citrulline min-1 g-1 tissue, P <0.001, n = 6 for each group). Similar results were obtained in animals treated with daily consecutive doses of leptin. The inhibitory effect appeared rapidly (within 30 min) and was long lasting (up to 12 h). 4. Our results suggest that the brain L-arginine/NO pathway may be involved in the central effect of leptin on feeding behaviour and body weight gain in mice.

KW - Body weight gain

KW - Brain

KW - Food intake

KW - L-arginine

KW - Leptin

KW - Nitric oxide

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=7844239801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7844239801&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0702121

DO - 10.1038/sj.bjp.0702121

M3 - Article

C2 - 9831917

AN - SCOPUS:7844239801

VL - 125

SP - 798

EP - 802

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -